Pregnancy and systemic lupus erythematosus;Grossesse et lupus systémique

Revue de Medecine Interne

Volumn 29, Issue 9, 2008, Pages 725-730

  Le Thi Huong D ^a   Wechsler, B ^a   Piette, J C ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Antiphospholipid syndrome; Pregnancy; Systemic lupus

Indexed keywords

ACETYLSALICYLIC ACID; CHORIONIC GONADOTROPIN; CYCLOPHOSPHAMIDE; HEPARIN; HYDROXYCHLOROQUINE; LEUPRORELIN; LIPOCORTIN 5; LIVER ENZYME; PHOSPHOLIPID ANTIBODY; PROTEIN C; STEROID;

ANTIPHOSPHOLIPID SYNDROME; AUTOIMMUNE DISEASE; CELL ACTIVATION; CELL ADHESION; CLINICAL PRACTICE; COMPLEMENT ACTIVATION; DISEASE ACTIVITY; DOPPLER ECHOGRAPHY; ENDOTHELIUM CELL; FEMALE FERTILITY; HELLP SYNDROME; HEMOLYSIS; HOMEOSTASIS; HUMAN; HYPERTENSION; MATERNAL MORBIDITY; NEWBORN MORBIDITY; NIDATION; OVARY INFLAMMATION; PREECLAMPSIA; PREGNANCY DISORDER; PREGNANCY OUTCOME; PREMATURITY; PRESCRIPTION; REPRODUCTION; SECOND TRIMESTER PREGNANCY; SHORT SURVEY; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS; TROPHOBLAST; UMBILICAL ARTERY;

FEMALE; FERTILITY; FETAL DISEASES; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; LUPUS ERYTHEMATOSUS, SYSTEMIC; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 50049107015     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2008.05.016     Document Type: Short Survey

References (38)

1. Silva C.A., Leal M.M., Leone C., Simone V.P., Takiuti A.D., Saito M.I., et al. Gonadal function in adolescents and young women with juvenile systemic lupus erythematosus. Lupus 11 (2002) 419-425
2. Pasoto S.G., Viana V.S., Mendonca B.B., Yoshinari N.H., and Bonfa E. Anti-corpus luteum antibody: a novel serological marker for ovarian dysfunction in systemic lupus erythematosus?. J Rheumatol 26 (1999) 1087-1093
3. Pierangeli S.S., Girardi G., Vega-Ostertag M., Liu X., Espinola R.G., and Salmon J. Requirement of activation of complement C3 and C5 for antiphospholipid antibody-mediated thrombophilia. Arthritis Rheum 52 (2005) 2120-2124
4. Le Thi Huong D., Wechsler B., and Piette J.C. Induction d'ovulation, lupus et antiphospholipides. Rev Med Interne 22 (2001) 111-117
5. Girardi G. Heparin treatment in pregnancy loss: Potential therapeutic benefits beyond anticoagulation. J Reprod Immunol 66 (2005) 45-51
6. Backos M., Rai R., and Regan L. Antiphospholipid antibodies and infertility. Hum Fertil (Camb) 5 (2002) 30-34
7. Le Thi Huong D., Amoura Z., Duhaut P., Sbai A., Costedoat N., Wechsler B., et al. Risk of ovarian failure and fertility after intravenous cyclophosphamide. A study in 84 patients. J Rheumatol 29 (2002) 2571-2576
8. Manger K., Wildt L., Kalden J.R., and Manger B. Prevention of gonadal toxicity and preservation of gonadal function and fertility in young women with systemic lupus erythematosus treated by cyclophosphamide: the PREGO study. Autoimmun Rev 5 (2006) 269-272
9. Somers E.C., Marder W., Christman G.M., Ognenovski V., and McCune W.J. Use of a gonadotropin-releasing hormone analog for protection against premature ovarian failure during cyclophosphamide therapy in women with severe lupus. Arthritis Rheum 52 (2005) 2761-2767
10. Moore R.A., and Derry S. Systematic review and meta-analysis of randomised trials and cohort studies of mycophenolate mofetil in lupus nephritis. Arthritis Res Ther 8 (2006) R182
11. Le Thi Huong D., Wechsler B., and Piette J.C. Rein, lupus et grossesse. Rev Med Interne 23 (2002) 813-818
12. Le Thi Huong D., Wechsler B., Piette J.C., Bletry O., and Godeau P. Registre français des grossesses lupiques. Le bilan. Rev Med Interne 15 (1994) 305-317
13. Le Thi Huong D., Wechsler B., Vauthier-Brouzes D., Seebacher J., Lefebvre G., Bletry O., et al. Outcome of planned pregnancies in systemic lupus erythematosus: a prospective study on 62 pregnancies. Br J Rheumatol 36 (1997) 772-777
14. Le Thi Huong D., Tieulie N., Costedoat N., Andreu M.R., Wechsler B., Vauthier-Brouzes D., et al. The HELLP syndrome in the antiphospholipid syndrome: retrospective study of 16 cases in 15 women. Ann Rheum Dis 64 (2005) 273-278
15. Le Thi Huong D., Wechsler B., Vauthier-Brouzes D., Beaufils H., Lefebvre G., and Piette J.C. Pregnancy in past or present lupus nephritis: a study of 32 pregnancies from a single centre. Ann Rheum Dis 60 (2001) 599-604
16. Soubassi L., Haidopoulos D., Sindos M., Pilalis A., Chaniotis D., Diakomanolis E., et al. Pregnancy outcome in women with preexisting lupus nephritis. J Obstet Gynaecol 24 (2004) 630-634
17. Carmona F., Font J., Moga I., Lazaro I., Cervera R., Pac V., et al. Class III-IV proliferative lupus nephritis and pregnancy: a study of 42 cases. Am J Reprod Immunol 53 (2005) 182-188
18. Tandon A., Ibanez D., Gladman D.D., and Urowitz M.B. The effect of pregnancy on lupus nephritis. Arthritis Rheum 50 (2004) 3941-3946
19. Toyota T., Yorioka N., Takahashi N., Moriishi M., Kawanishi H., Tsuchiya T., et al. Successful birth in a hemodialysis patient with SLE. Nephron 65 (1993) 331-332
20. Costedoat-Chalumeau N., Amoura Z., Aymard G., Le T.H., Wechsler B., Vauthier D., et al. Evidence of transplacental passage of hydroxychloroquine in humans. Arthritis Rheum 46 (2002) 1123-1124
21. Levy R.A., Vilela V.S., Cataldo M.J., Ramos R.C., Duarte J.L., Tura B.R., et al. Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study. Lupus 10 (2001) 401-404
22. Costedoat-Chalumeau N., Amoura Z., Duhaut P., Huong du L.T., Sebbough D., Wechsler B., et al. Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of 133 cases compared with a control group. Arthritis Rheum 48 (2003) 3207-3211
23. Clowse M.E., Magder L., Witter F., and Petri M. Hydroxychloroquine in lupus pregnancy. Arthritis Rheum 54 (2006) 3640-3647
24. Costedoat-Chalumeau N., Amoura Z., Huong D.L., Lechat P., and Piette J.C. Safety of hydroxychloroquine in pregnant patients with connective tissue diseases. Review of the literature. Autoimmun Rev 4 (2005) 111-115
25. Ostensen M., Khamashta M., Lockshin M., Parke A., Brucato A., Carp H., et al. Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther 8 (2006) 209
26. Hussein M.M., Mooij J.M., and Roujouleh H. Cyclosporine in the treatment of lupus nephritis including two patients treated during pregnancy. Clin Nephrol 40 (1993) 160-163
27. Le Thi Huong D., Wechsler B., Vauthier-Brouzes D., Duhaut P., Costedoat N., Andreu M.R., et al. The second trimester Doppler ultrasound examination is the best predictor of late pregnancy outcome in systemic lupus erythematosus and/or the antiphospholipid syndrome. Rheumatology (Oxford) 45 (2006) 332-338
28. Castellino G., Capucci R., Govoni M., Mollica G., and Trotta F. Uterine artery Doppler in predicting pregnancy outcome in women with connective tissue disorders. Rheumatology (Oxford) 45 (2006) 1174-1175
29. Costedoat-Chalumeau N., Amoura Z., Le Thi Hong D., Wechsler B., Vauthier D., Ghillani P., et al. Questions about dexamethasone use for the prevention of anti-SSA related congenital heart block. Ann Rheum Dis 62 (2003) 1010-1012
30. Costedoat-Chalumeau N., Amoura Z., Villain E., Cohen L., Fermont L., Le Thi Huong D., et al. Prise en charge obstétricale des patientes à risque de lupus néonatal. Revue de la littérature. J Gynecol Obstet Biol Reprod (Paris) 35 (2006) 146-156
31. Costedoat-Chalumeau N., Amoura Z., Lupoglazoff J.M., Thi Huong du L., Denjoy I., Vauthier D., et al. Outcome of pregnancies in patients with anti-SSA/Ro antibodies: a study of 165 pregnancies, with special focus on electrocardiographic variations in the children and comparison with a control group. Arthritis Rheum 50 (2004) 3187-3194
32. Stea E.A., Routsias J.G., Clancy R.M., Buyon J.P., Moutsopoulos H.M., and Tzioufas A.G. Anti-La/SSB antiidiotypic antibodies in maternal serum: a marker of low risk for neonatal lupus in an offspring. Arthritis Rheum 54 (2006) 2228-2234
33. Wilson W.A., Gharavi A.E., Koike T., Lockshin M.D., Branch D.W., Piette J.C., et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 42 (1999) 1309-1311
34. Cowchock F.S., Reece E.A., Balaban D., Branch D.W., and Plouffe L. Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment. Am J Obstet Gynecol 166 (1992) 1318-1323
35. Silver R.K., MacGregor S.N., Sholl J.S., Hobart J.M., Neerhof M.G., and Ragin A. Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients. Am J Obstet Gynecol 169 (1993) 1411-1417
36. Rai R., Cohen H., Dave M., and Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ 314 (1997) 253-257
37. Kutteh W.H. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol 174 (1996) 1584-1589
38. Piette J.C., Huong D.L., and Wechsler B. Treatment of pregnant women with recurrent miscarriage associated with phospholipid antibodies. During pregnancy, heparin should be stopped during labour and then restarted soon after delivery. BMJ 315 (1997) 372-373